Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Xiaoshe Chen"'
Autor:
Nelly G. Adel, L Reich, Melissa Pozotrigo, Elyn Riedel, Hani Hassoun, Nikoletta Lendvai, Xiaoshe Chen, Alexander M. Lesokhin, Sergio Giralt, David J. Chung, Danielle Chimento, Raymond L. Comenzo, Heather Landau
Publikováno v:
Bone Marrow Transplantation. 48:1033-1039
Thalidomide, lenalidomide and bortezomib have increasingly been incorporated in first-line induction therapies for multiple myeloma. Concerns regarding the impact of these agents, especially lenalidomide, on stem cell mobilization prompted us to re-e
Autor:
M. Malloy, R.C. Meagher, Sharon Bleau, Katherine Smith, Peter Maslak, Ann A. Jakubowski, Melissa S. Pessin, Sergio Giralt, Xiaoshe Chen, Sean M. Devlin, Nancy H. Collins, R.J. O'Reilly, Jo-ann Tonon, Guenther Koehne
Publikováno v:
Cytotherapy. 15:S22-S23
Autor:
Vincent LaRussa, Lilian Reich, Sergio Giralt, Elyn Riedel, Hani Hassoun, Xiaoshe Chen, Melissa Pozotrigo, Heather Landau, Nelly G. Adel
Publikováno v:
Blood. 116:2262-2262
Abstract 2262 Background: In the past decade, novel agents including thalidomide, lenalidomide, and bortezomib have increasingly been incorporated in first line induction therapies in the treatment of MM with the aim of achieving the highest response
Autor:
Lilian Reich, Xiaoshe Chen, Nancy H. Collins, Stephen D. Nimer, Bradly D. Clark, Martin Fleisher, Hani Hassoun, Julie Teruya-Feldstein, Ping Zhou, Raymond L. Comenzo, David Wuest, Andre Nuta
Publikováno v:
Blood. 108:3087-3087
Systemic light-chain (AL) amyloidosis is both a protein deposition disorder and a monoclonal plasma cell dyscrasia. Effective treatment depends on reduction of the clonal plasma cells that produce the toxic light chains. Although high-dose melphalan